Read about our fascinating discoveries around the pain-relieving effect of the JAK inhibitor baricitinib in an arthritis context !
Our pre-clinical study highlights exciting findings and is now available in the prestigious journal ARD: www.sciencedirect.com/science/arti...
Read about our fascinating discoveries around the pain-relieving effect of the JAK inhibitor baricitinib in an arthritis context !
Our pre-clinical study highlights exciting findings and is now available in the prestigious journal ARD: www.sciencedirect.com/science/arti...
Read about our fascinating discoveries around the pain-relieving effect of the JAK inhibitor baricitinib in an arthritis context !
Our pre-clinical study highlights exciting findings and is now available in the prestigious journal ARD: www.sciencedirect.com/science/arti...
🗓️ 7–13 June 2025
📍 Certosa di Pontignano, Siena – a stunning setting for cutting-edge learning.
📝 Apply by: 28 February 2025 eps2025.azuleon.org/application
💡 This year’s focus: Cancer Pain Research, featuring topics like:
Celebrating an incredible achievement! 🎉 Huge congratulations to Dr. Nils Simon on an amazing PhD defense! His work titled "Autoantibodies and Chronic Pain: Unraveling Molecular Mechanisms in Rheumatoid Arthritis" is truly inspiring.👏 #RheumatoidArthritis #Science
Curious about how autoantibodies contribute to chronic pain in rheumatoid arthritis and fibromyalgia? Our lab at KI is diving deep into this connection to uncover new insights! 🧪🔬 You can scroll through our work here: pubmed.ncbi.nlm.nih.gov?term=Svensso...
Curious about how autoantibodies contribute to chronic pain in rheumatoid arthritis and fibromyalgia? Our lab at KI is diving deep into this connection to uncover new insights! 🧪🔬 You can scroll through our work here: pubmed.ncbi.nlm.nih.gov?term=Svensso...